Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Target enrollment reached in phase III trial of Interferon's Alferon N Injection

June 6, 1997

LXR refocuses Lexirin development

June 6, 1997

Schering-Plough Research Institute reveals structure of enzyme in HCV life cycle

June 6, 1997

U.S. patent covers use of Synsorb Cd in C. difficile-associated diarrhea

June 5, 1997

Axcan acquires U.S. rights to Viokase

June 5, 1997

Proarrhythmia associated with cisapride; exacerbation by cytochrome P-450 inhibitors

June 3, 1997

Janssen characterizes new enterokinetic agent

May 30, 1997

New immunomodulator from Orion with potential in IBD

May 30, 1997

New medicines under development for IBD reported at DDW

May 30, 1997

Oxis International moves IBD therapy to phase II

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...